Citizens JMP Reiterates Market Outperform Rating on Structure Therapeutics (GPCR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| (NASDAQ: GPCR) | Delayed: 21.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.87 | 52 Week High | $ | |||
| Open | $21.87 | 52 Week Low | $ | |||
| Day High | $21.87 | P/E | N/A | |||
| Day Low | $21.87 | EPS | $ | |||
| Volume | 3,656 | |||||
